These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
284 related articles for article (PubMed ID: 24859269)
1. Embryo-fetal exposure and developmental outcome of thalidomide following oral and intravaginal administration to pregnant rabbits. Hui JY; Hoffmann M; Kumar G Reprod Toxicol; 2014 Sep; 48():115-23. PubMed ID: 24859269 [TBL] [Abstract][Full Text] [Related]
2. Species-specificity of ethylene glycol-induced developmental toxicity: toxicokinetic and whole embryo culture studies in the rabbit. Carney EW; Tornesi B; Markham DA; Rasoulpour RJ; Moore N Birth Defects Res B Dev Reprod Toxicol; 2008 Dec; 83(6):573-81. PubMed ID: 19025792 [TBL] [Abstract][Full Text] [Related]
3. Common nature in the effects of thalidomide on embryo-fetal development in Kbl:JW and Kbl:NZW rabbits. Kawamura Y; Shirotsuka Y; Awatsuji H; Matsumoto K; Sato K Congenit Anom (Kyoto); 2014 Feb; 54(1):41-53. PubMed ID: 24206199 [TBL] [Abstract][Full Text] [Related]
4. Evaluation of the developmental toxicity of lenalidomide in rabbits. Christian MS; Laskin OL; Sharper V; Hoberman A; Stirling DI; Latriano L Birth Defects Res B Dev Reprod Toxicol; 2007 Jun; 80(3):188-207. PubMed ID: 17570132 [TBL] [Abstract][Full Text] [Related]
5. Effects of thalidomide on developmental, peri- and postnatal function in female New Zealand white rabbits and offspring. Teo SK; Denny KH; Stirling DI; Thomas SD; Morseth S; Hoberman AM Toxicol Sci; 2004 Oct; 81(2):379-89. PubMed ID: 15229368 [TBL] [Abstract][Full Text] [Related]
6. Critical period for a teratogenic VLA-4 antagonist: Developmental effects and comparison of embryo drug concentrations of teratogenic and non-teratogenic VLA-4 antagonists. Crofts F; Rohatagi S; Pino M; DeLise B; Zhang J; Nguyen M; Guittin P; Barbellion S; Brunel P; Hofmann T; Schmidt J; Wong M; Lockey P; Lerman S; Clark R Birth Defects Res B Dev Reprod Toxicol; 2004 Apr; 71(2):69-79. PubMed ID: 15098200 [TBL] [Abstract][Full Text] [Related]
7. Assessment of fetal exposure risk following seminal excretion of a therapeutic IgG4 (T-IgG4) monoclonal antibody using a rabbit model. Breslin WJ; Hilbish KG; Page TJ; Coutant DE Reprod Toxicol; 2014 Sep; 48():124-31. PubMed ID: 24863471 [TBL] [Abstract][Full Text] [Related]
8. Differential alteration by thalidomide of the glutathione content of rat vs. rabbit conceptuses in vitro. Hansen JM; Carney EW; Harris C Reprod Toxicol; 1999; 13(6):547-54. PubMed ID: 10613403 [TBL] [Abstract][Full Text] [Related]
9. Prenatal developmental toxicity of decabromodiphenyl ethane in the rat and rabbit. Hardy ML; Mercieca MD; Rodwell DE; Stedeford T Birth Defects Res B Dev Reprod Toxicol; 2010 Apr; 89(2):139-46. PubMed ID: 20437473 [TBL] [Abstract][Full Text] [Related]
10. Mechanisms regulating toxicant disposition to the embryo during early pregnancy: an interspecies comparison. Carney EW; Scialli AR; Watson RE; DeSesso JM Birth Defects Res C Embryo Today; 2004 Dec; 72(4):345-60. PubMed ID: 15662707 [TBL] [Abstract][Full Text] [Related]
11. Different embryo-fetal toxicity effects for three VLA-4 antagonists. Crofts F; Pino M; DeLise B; Guittin P; Barbellion S; Brunel P; Potdevin S; Bergmann B; Hofmann T; Lerman S; Clark RL Birth Defects Res B Dev Reprod Toxicol; 2004 Apr; 71(2):55-68. PubMed ID: 15098199 [TBL] [Abstract][Full Text] [Related]
12. Evaluation of early fetal exposure to vaginally-administered metronidazole in pregnant cynomolgus monkeys. Thompson KE; Newcomb DL; Moffat GJ; Zalikowski J; Chellman GJ; McNerney ME Reprod Toxicol; 2016 Jan; 59():17-21. PubMed ID: 26524246 [TBL] [Abstract][Full Text] [Related]
13. Developmental toxicity of the HMG-CoA reductase inhibitor (PPD10558) in rats and rabbits. Faqi AS; Prohaska D; Lopez R; McIntyre G Birth Defects Res B Dev Reprod Toxicol; 2012 Feb; 95(1):23-37. PubMed ID: 22006546 [TBL] [Abstract][Full Text] [Related]
14. Distribution, teratogenicity, and embryonic delivered dose of retinoid Ro 23-9223. Willhite CC; Lovey A; Eckhoff C Toxicol Appl Pharmacol; 2000 Apr; 164(2):171-5. PubMed ID: 10764630 [TBL] [Abstract][Full Text] [Related]
15. Fluorothalidomide: a characterization of maternal and developmental toxicity in rabbits and mice. Lee CJ; Shibata N; Wiley MJ; Wells PG Toxicol Sci; 2011 Jul; 122(1):157-69. PubMed ID: 21505091 [TBL] [Abstract][Full Text] [Related]
16. Embryo-Fetal Developmental Toxicity Studies with Pregabalin in Mice and Rabbits. Morse DC Birth Defects Res B Dev Reprod Toxicol; 2016 Apr; 107(2):85-93. PubMed ID: 27044003 [TBL] [Abstract][Full Text] [Related]
18. Stability of the reproductive variables and fetal malformations from control animals and animals treated with thalidomide in Kbl:JW rabbits over two decades. Kawamura Y; Matsumoto K; Sato K Congenit Anom (Kyoto); 2012 Dec; 52(4):191-202. PubMed ID: 23181494 [TBL] [Abstract][Full Text] [Related]
19. Interaction of thalidomide with DNA of rabbit embryos: a possible explanation for its immunosuppressant and teratogenic effects. Huang PH; McBride WG; Tuman WG Pharmacol Toxicol; 1999 Aug; 85(2):103-4. PubMed ID: 10488693 [TBL] [Abstract][Full Text] [Related]
20. Fetal malformations and early embryonic gene expression response in cynomolgus monkeys maternally exposed to thalidomide. Ema M; Ise R; Kato H; Oneda S; Hirose A; Hirata-Koizumi M; Singh AV; Knudsen TB; Ihara T Reprod Toxicol; 2010 Jan; 29(1):49-56. PubMed ID: 19751816 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]